SCHEMBL6899409

SCHEMBL6899409

CC(C)[Si]1(C(C)C)OC[C@H]2O[C@@H](n3cnc4c(N)nc(Cl)nc43)C[C@@H]2O[Si](C(C)C)(C(C)C)O1

nearest known ligand 0.49

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
▸ PDE4D Q08499 2/20 0.49
▸ PDE3A Q14432 2/20 0.49
▸ PNP P00491 1/20 0.49
▸ LMNA P02545 1/20 0.49
▸ TP53 P04637 1/20 0.49
▸ HTT P42858 1/20 0.49
▸ SMN1; SMN2 Q16637 1/20 0.49
▸ RXFP1 Q9HBX9 1/20 0.49
▸ NT5E P21589 2/20 0.43
▸ ADORA3 P0DMS8 8/20 0.43
▸ ADORA2A P29274 3/20 0.41
▸ ADORA1 P30542 2/20 0.41
▸ STING1 Q86WV6 2/20 0.41
▸ PDE2A O00408 1/20 0.38
▸ ADRA1A P35348 1/20 0.38
▸ CDK1 P06493 1/20 0.38
▸ HSP90AA1 P07900 1/20 0.38
▸ HSP90B1 P14625 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7894271 0.89 AHCY (0.46) PDE4DPDE3APNPLMNATP53
SCHEMBL8668421 0.87 NT5E (0.36) PDE4DPDE3APNPLMNATP53
SCHEMBL12729578 0.85 STING1 (0.52) TP53ADORA3ADORA2AADORA1STING1
SCHEMBL12222444 0.85 STING1 (0.52) TP53ADORA3ADORA2AADORA1STING1
SCHEMBL12595500 0.85 STING1 (0.52) TP53ADORA3ADORA2AADORA1STING1
SCHEMBL12352439 0.85 STING1 (0.52) TP53ADORA3ADORA2AADORA1STING1
SCHEMBL8624094 0.85 STING1 (0.52) TP53ADORA3ADORA2AADORA1STING1
SCHEMBL17772331 0.85 STING1 (0.52) TP53ADORA3ADORA2AADORA1STING1
SCHEMBL10719650 0.85 ADORA3 (0.37) PDE4DPDE3APNPLMNATP53
SCHEMBL20305241 0.83 ADORA3 (0.46) PDE4DPDE3APNPLMNATP53

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0604409-B1 OLIGONUCLEOTIDE ANALOGS FOR DETECTING AND MODULATING RNA ACTIVITY AND GENE EXPRESSION ISIS PHARMACEUTICALS INC (US) 2004-07-14 — — EP disclosed
EP-1418179-A2 Compositions and methods for detecting and modulating rna activity and gene expression ISIS PHARMACEUTICALS, INC. (US) 2004-05-12 — — EP disclosed
US-6262241-B1 ANTISENSE COMPOUNDS WHICH CLEAVE PHOSPHORODIESTER BONDS AND IMPROVE PHARMACODYNAMIC AND PHARMACOKINETIC PROPERTIES OF OLIGONUCLEOTIDES, USEFUL IN DIAGNOSING DISEASES ISIS PHARMACEUTICALS, INC. 2001-07-17 — — US disclosed
Send feedback